{"id":2443,"date":"2026-02-26T11:12:39","date_gmt":"2026-02-26T18:12:39","guid":{"rendered":"https:\/\/www.ultalabtests.com\/blog\/?p=2443"},"modified":"2026-02-28T09:07:07","modified_gmt":"2026-02-28T16:07:07","slug":"vascular-aging-cardiovascular-risk-labs-prevention-therapy","status":"publish","type":"post","link":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/","title":{"rendered":"Vascular Aging &amp; Cardiovascular Risk: Labs, Prevention, Therapy"},"content":{"rendered":"\n<p id=\"h-\">Vascular aging is not simply \u201ctime passing.\u201d It is a measurable, biologically driven remodeling of the arterial system\u2014centered on endothelial dysfunction,&nbsp;<strong>Arterial Stiffness<\/strong>&nbsp;(often described as&nbsp;<strong>artery stiffness<\/strong>), vascular inflammation, and calcific\/atherosclerotic progression\u2014that ultimately amplifies risk for ASCVD, hypertension, coronary heart disease, stroke, heart failure (especially HFpEF), kidney disease, and cognitive decline. Clinically, these changes show up as a rising&nbsp;<strong>vascular age<\/strong>\u2014meaning your arteries can behave \u201colder\u201d than your chronological age long before symptoms appear.<\/p>\n\n\n\n<p id=\"h-\">In practice, vascular aging is the \u201csoil\u201d in which atherosclerosis and hypertension flourish. When artery stiffness increases, pulsatile pressure and shear stress rise, endothelial function worsens, and plaque progression accelerates\u2014making Arterial Stiffness a cornerstone marker for early risk detection and targeted prevention.<\/p>\n\n\n\n<p>A clinically useful framework is to treat vascular aging as a&nbsp;<strong>detectable, trackable, and modifiable intermediate phenotype<\/strong>\u2014one that often appears&nbsp;<strong>before<\/strong>&nbsp;overt cardiovascular events. Endothelial dysfunction is widely described as among the earliest features of vascular aging and is strongly linked to downstream atherosclerosis and adverse outcomes.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"427\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Labs-Prevention-Therapy-Medium.jpeg?resize=640%2C427&#038;quality=100&#038;ssl=1\" alt=\"Wide banner showing atherosclerotic artery cross-section, heart illustration, and lab vials labeled ApoB, Lp(a), hs-CRP, and A1c with prevention and therapy icons.\" class=\"wp-image-2445\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Labs-Prevention-Therapy-Medium.jpeg?w=640&amp;quality=100&amp;ssl=1 640w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Labs-Prevention-Therapy-Medium.jpeg?resize=300%2C200&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Labs-Prevention-Therapy-Medium.jpeg?resize=600%2C400&amp;quality=100&amp;ssl=1 600w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><figcaption class=\"wp-element-caption\">A visual overview of vascular aging\u2014plaque buildup, key biomarkers, and clinical strategies to reduce ASCVD and hypertension risk.<br><\/figcaption><\/figure>\n\n\n\n<p>This article provides a clinician-focused, evidence-based roadmap for:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Understanding the&nbsp;<strong>pathways<\/strong>&nbsp;of vascular aging and how they drive cardiovascular disease (CVD)<\/li>\n\n\n\n<li>Implementing&nbsp;<strong>diagnostic approaches<\/strong>&nbsp;for early detection (functional + structural + laboratory)<\/li>\n\n\n\n<li>Applying&nbsp;<strong>prevention and treatment strategies<\/strong>&nbsp;(nutrition, supplements, peptide\/biologic therapies, and pharmacology)<\/li>\n\n\n\n<li>Selecting&nbsp;<strong>high-yield lab tests<\/strong>&nbsp;for atherosclerosis, coronary heart disease, and related conditions<\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-group has-light-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<p><strong>Three Panels, One Goal: Measure Vascular Aging, Refine Risk, and Monitor Impact<\/strong><\/p>\n\n\n\n<p>C<strong>hoose Your Panel (Quick Guide)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Baseline (Start Here):<\/strong>\u00a0<a href=\"https:\/\/www.ultalabtests.com\/test\/vascular-aging-arterial-health-baseline-panel\" target=\"_blank\" rel=\"noreferrer noopener\"><em>Vascular Aging &amp; Arterial Health Baseline Panel<\/em>\u00a0<\/a>\u2014 establishes your core vascular risk profile (ApoB, Lp(a), inflammation, A1c, CMP, urine albumin).<\/li>\n\n\n\n<li><strong>Risk Refinement (Go Deeper):<\/strong>\u00a0<a href=\"https:\/\/www.ultalabtests.com\/test\/atherosclerosis-coronary-heart-disease-risk-refinement-panel\" target=\"_blank\" rel=\"noreferrer noopener\"><em>Atherosclerosis &amp; Coronary Heart Disease Risk Refinement Panel<\/em>\u00a0<\/a>\u2014 adds advanced particle testing (Ion Mobility) plus homocysteine and TSH to sharpen coronary risk.<\/li>\n\n\n\n<li><strong>Impact Monitoring (Ongoing Surveillance):<\/strong>\u00a0<a href=\"https:\/\/www.ultalabtests.com\/test\/vascular-aging-impact-end-organ-surveillance-panel\" type=\"link\" id=\"https:\/\/www.ultalabtests.com\/test\/vascular-aging-impact-end-organ-surveillance-panel\"><em>Vascular Aging Impact &amp; End-Organ Surveillance <\/em><\/a><em><a href=\"https:\/\/www.ultalabtests.com\/test\/vascular-aging-impact-end-organ-surveillance-panel\" type=\"link\" id=\"https:\/\/www.ultalabtests.com\/test\/vascular-aging-impact-end-organ-surveillance-panel\" target=\"_blank\" rel=\"noreferrer noopener\">Panel<\/a><\/em><a href=\"https:\/\/www.ultalabtests.com\/test\/vascular-aging-impact-end-organ-surveillance-panel\" type=\"link\" id=\"https:\/\/www.ultalabtests.com\/test\/vascular-aging-impact-end-organ-surveillance-panel\">\u00a0<\/a>\u2014 tracks downstream effects with NT-proBNP, hs-Troponin T, CBC, CMP, A1c, and urine albumin for structured follow-up.<\/li>\n<\/ul>\n<\/div><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-1-core-biology-what-changes-as-vessels-age\">1) Core biology: what changes as vessels \u201cage\u201d?<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-a-endothelial-dysfunction-the-gatekeeper-failure\">A. Endothelial dysfunction (the \u201cgatekeeper\u201d failure)<\/h3>\n\n\n\n<p>Healthy endothelium regulates vasodilation (via nitric oxide), platelet activity, leukocyte adhesion, and smooth muscle tone. With aging and cardiometabolic stressors (BP load, glucose variability, dyslipidemia, sleep disruption), the endothelium shifts toward:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u2193 Nitric oxide bioavailability<\/li>\n\n\n\n<li>\u2191 Oxidative stress<\/li>\n\n\n\n<li>\u2191 Vascular inflammation and adhesion molecule expression<\/li>\n\n\n\n<li>\u2191 Pro-thrombotic signaling<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-full\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"427\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Pathway-From-Endothelial-Dysfunction-to-Events-Medium-1.jpeg?resize=640%2C427&#038;quality=100&#038;ssl=1\" alt=\"Infographic showing the vascular aging pathway: endothelial dysfunction \u2192 inflammation\/oxidative stress \u2192 arterial stiffness \u2192 plaque progression \u2192 cardiovascular events (heart attack, stroke, PAD).\" class=\"wp-image-2447\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Pathway-From-Endothelial-Dysfunction-to-Events-Medium-1.jpeg?w=640&amp;quality=100&amp;ssl=1 640w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Pathway-From-Endothelial-Dysfunction-to-Events-Medium-1.jpeg?resize=300%2C200&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Pathway-From-Endothelial-Dysfunction-to-Events-Medium-1.jpeg?resize=600%2C400&amp;quality=100&amp;ssl=1 600w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><figcaption class=\"wp-element-caption\">A 5-step visual summary of how vascular aging progresses from early endothelial dysfunction to plaque-driven cardiovascular events.<\/figcaption><\/figure>\n\n\n\n<p>This is why endothelial dysfunction is often described as an early hallmark of vascular aging and a pivotal precursor to atherosclerosis.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-b-arterial-stiffening-loss-of-windkessel-function\">B. Arterial stiffening (loss of \u201cWindkessel\u201d function)<\/h3>\n\n\n\n<p>Large elastic arteries (aorta) normally buffer pulsatile ejection and protect the microcirculation. With vascular aging:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Elastin fragments, collagen increases\/cross-links<\/li>\n\n\n\n<li>Smooth muscle tone and extracellular matrix architecture change<\/li>\n\n\n\n<li>Calcification progresses<\/li>\n\n\n\n<li>Pulse pressure widens, afterload rises, and reflected waves return earlier<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Arterial-Stiffness-Pulse-Wave-Velocity.png?resize=1024%2C683&#038;quality=100&#038;ssl=1\" alt=\"Side-by-side explainer showing a flexible aorta with normal pulse wave velocity (PWV) versus a stiff, plaque-affected aorta with increased PWV, with pulse wave arrows and the label \u201cPWV increases with stiffness.\u201d\" class=\"wp-image-2448\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Arterial-Stiffness-Pulse-Wave-Velocity.png?resize=1024%2C683&amp;quality=100&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Arterial-Stiffness-Pulse-Wave-Velocity.png?resize=300%2C200&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Arterial-Stiffness-Pulse-Wave-Velocity.png?resize=768%2C512&amp;quality=100&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Arterial-Stiffness-Pulse-Wave-Velocity.png?resize=600%2C400&amp;quality=100&amp;ssl=1 600w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Arterial-Stiffness-Pulse-Wave-Velocity.png?w=1536&amp;quality=100&amp;ssl=1 1536w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">Pulse wave velocity increases as arteries stiffen\u2014an accessible visual anchor for \u201cvascular age\u201d and cardiovascular risk.<\/figcaption><\/figure>\n\n\n\n<p><strong>Pulse wave velocity (PWV)<\/strong>&nbsp;is an established biomarker of arterial stiffness and cardiovascular risk. <br>European hypertension guidance recognizes&nbsp;<strong>carotid\u2013femoral PWV (cfPWV)<\/strong>&nbsp;as a reference (\u201cgold standard\u201d) method, with higher values associated with increased risk and target-organ damage. <\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-c-vascular-inflammation-immunometabolic-signaling\">C. Vascular inflammation + immunometabolic signaling<\/h3>\n\n\n\n<p>Chronic low-grade inflammation accelerates endothelial dysfunction, promotes plaque vulnerability, and interacts with senescence-associated signaling (\u201cinflammaging\u201d). Anti-inflammatory approaches (lifestyle first; pharmacology in select high-risk patients) matter because inflammation is not just a bystander\u2014it is causal in atherosclerotic progression and events (as supported by multiple outcome trials targeting inflammation).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-d-calcification-and-glycation-driven-hardening\">D. Calcification and glycation-driven \u201chardening\u201d<\/h3>\n\n\n\n<p>With aging, diabetes, CKD, and high phosphate states, vascular calcification and advanced glycation end-products (AGEs) worsen stiffness and impair vasoreactivity. Clinically, this shows up as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Higher pulse pressure<\/li>\n\n\n\n<li>Elevated CAC scores<\/li>\n\n\n\n<li>\u201cOlder\u201d arterial phenotype than expected for chronological age<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-2-clinical-consequences-how-vascular-aging-drives-disease\">2) Clinical consequences: how vascular aging drives disease<\/h2>\n\n\n\n<p>Vascular aging is a convergence point that increases risk for:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Atherosclerotic cardiovascular disease (ASCVD)<\/strong>&nbsp;(CAD, MI, stroke, PAD)<\/li>\n\n\n\n<li><strong>Hypertension<\/strong>&nbsp;and resistant hypertension<\/li>\n\n\n\n<li><strong>HFpEF<\/strong>&nbsp;(stiff arteries \u2192 stiff ventricle coupling)<\/li>\n\n\n\n<li><strong>CKD progression<\/strong>&nbsp;(microvascular damage)<\/li>\n\n\n\n<li><strong>Cerebrovascular disease<\/strong>&nbsp;and cognitive decline<\/li>\n<\/ul>\n\n\n\n<p>A key clinical insight:&nbsp;<strong>vascular age often diverges from chronological age<\/strong>. Two 60-year-olds can have profoundly different arterial biology\u2014and therefore different risk trajectories.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-3-early-detection-a-practical-diagnostic-approach\">3) Early detection: a practical diagnostic approach<\/h2>\n\n\n\n<p>An ideal evaluation combines:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Risk estimation<\/strong><\/li>\n\n\n\n<li><strong>Functional vascular testing<\/strong>&nbsp;(endothelial function, stiffness)<\/li>\n\n\n\n<li><strong>Structural disease detection<\/strong>&nbsp;(plaque burden\/calcification)<\/li>\n\n\n\n<li><strong>Laboratory risk phenotype<\/strong>&nbsp;(atherogenic particles, inflammation, thrombosis\/metabolic drivers)<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-step-1-risk-estimation-risk-enhancers\">Step 1 \u2014 Risk estimation + \u201crisk enhancers\u201d<\/h3>\n\n\n\n<p>Start with guideline-based risk assessment and then refine using risk enhancers:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ApoB (atherogenic particle burden; especially when LDL-C is discordant)<\/li>\n\n\n\n<li>Lipoprotein(a) [Lp(a)] (genetically determined; strong ASCVD association)<\/li>\n<\/ul>\n\n\n\n<p>Many contemporary expert sources and society statements support measuring&nbsp;<strong>Lp(a) at least once in adulthood<\/strong>, because it is largely genetically determined and identifies otherwise \u201chidden\u201d risk. <br>ApoB is also increasingly emphasized as a strong predictor of ASCVD risk, particularly in discordant lipid states. <\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-step-2-functional-vascular-testing-detects-early-vascular-aging\">Step 2 \u2014 Functional vascular testing (detects early vascular aging)<\/h3>\n\n\n\n<p><strong>Arterial stiffness<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>cfPWV<\/strong>&nbsp;(reference standard in many settings)<\/li>\n\n\n\n<li>Brachial-ankle PWV (baPWV) or estimated PWV where available<br>PWV is widely recognized as a clinically meaningful biomarker of vascular aging and risk. <\/li>\n<\/ul>\n\n\n\n<p><strong>Central blood pressure and pulse pressure<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Widening pulse pressure can reflect arterial stiffening<\/li>\n<\/ul>\n\n\n\n<p><strong>Endothelial function testing<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Reactive hyperemia index (RHI) by peripheral arterial tonometry<\/li>\n\n\n\n<li>Flow-mediated dilation (FMD; research\/vascular labs)<\/li>\n<\/ul>\n\n\n\n<p>These tests are useful when the goal is to identify vascular aging&nbsp;<em>before<\/em>&nbsp;plaque is detectable.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-step-3-structural-assessment-detects-subclinical-atherosclerosis\">Step 3 \u2014 Structural assessment (detects subclinical atherosclerosis)<\/h3>\n\n\n\n<p><strong>Coronary artery calcium (CAC)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Strong risk stratifier, particularly in intermediate-risk patients<\/li>\n\n\n\n<li>Helpful when treatment decisions are uncertain<\/li>\n<\/ul>\n\n\n\n<p><strong>Carotid ultrasound<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Carotid plaque and IMT (intima-media thickness) for burden<\/li>\n<\/ul>\n\n\n\n<p><strong>ABI (ankle-brachial index)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>PAD detection; systemic atherosclerosis marker<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-step-4-laboratory-phenotyping-what-to-measure-and-why\">Step 4 \u2014 Laboratory phenotyping (what to measure and why)<\/h3>\n\n\n\n<p>For vascular aging, labs should identify:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Atherogenic particle burden<\/strong><\/li>\n\n\n\n<li><strong>Inflammation<\/strong><\/li>\n\n\n\n<li><strong>Metabolic\/endothelial stress<\/strong><\/li>\n\n\n\n<li><strong>Thrombotic risk<\/strong><\/li>\n\n\n\n<li><strong>Organ impact<\/strong>&nbsp;(kidney, liver, myocardium)<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-4-lab-testing-for-vascular-aging-linked-cardiovascular-disease-ulta-lab-tests-clinical-menu-options\">4) Lab testing for vascular aging\u2013linked cardiovascular disease (Ulta Lab Tests clinical menu options)<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"427\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Biomarker-Dashboard-Key-Labs-for-Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?resize=640%2C427&#038;quality=100&#038;ssl=1\" alt=\"Minimal biomarker dashboard with six tiles labeled ApoB, Lp(a), hs-CRP, A1c, uACR, and NT-proBNP, each with a simple icon and short label.\" class=\"wp-image-2450\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Biomarker-Dashboard-Key-Labs-for-Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?w=640&amp;quality=100&amp;ssl=1 640w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Biomarker-Dashboard-Key-Labs-for-Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?resize=300%2C200&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Biomarker-Dashboard-Key-Labs-for-Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?resize=600%2C400&amp;quality=100&amp;ssl=1 600w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><figcaption class=\"wp-element-caption\">A quick-look lab dashboard highlighting the six biomarkers that help detect particle risk, inherited risk, inflammation, metabolic stress, microvascular injury, and cardiac strain.<\/figcaption><\/figure>\n\n\n\n<p>Below are clinician-friendly lab groupings commonly used to evaluate vascular aging, atherosclerosis, coronary heart disease risk, and related conditions. <\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-a-atherosclerosis-amp-particle-burden-core\">A. Atherosclerosis &amp; particle burden (core)<\/h3>\n\n\n\n<p><strong>Why it matters:<\/strong>&nbsp;Vascular aging accelerates plaque initiation and progression; particle burden and apoB-containing lipoproteins are the \u201cdelivery vehicles\u201d for arterial wall cholesterol.<\/p>\n\n\n\n<p>High-yield tests:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/lipid-panel-test\">Lipid panel<\/a><\/strong>&nbsp;(LDL-C, HDL-C, TG, non\u2013HDL-C)<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/apolipoprotein-b-test\">Apolipoprotein B (ApoB<\/a>)<\/strong><\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/lipoprotein-a-test\">Lipoprotein(a) [Lp(a)]<\/a><\/strong>&nbsp;(at least once in adulthood; repeat selectively)<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/cardio-iq-lipoprotein-fractionation-test-ion-mobility\">Advanced lipoprotein testing<\/a><\/strong>&nbsp;(LDL particle number\/size, remnant metrics) when discordance\/metabolic syndrome suspected<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-b-inflammation-amp-plaque-activity\">B. Inflammation &amp; plaque activity<\/h3>\n\n\n\n<p><strong>Why it matters:<\/strong>&nbsp;Inflammation is a driver of plaque vulnerability and events.<\/p>\n\n\n\n<p>High-yield tests:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/hs-crp-test\">hs-CRP<\/a><\/strong><\/li>\n\n\n\n<li>Optional (case-dependent): <a href=\"https:\/\/www.ultalabtests.com\/test\/fibrinogen-activity-test\">fibrinogen<\/a>, <a href=\"https:\/\/www.ultalabtests.com\/test\/lp-pla2-activity-test\">Lp-PLA2<\/a>, <a href=\"https:\/\/www.ultalabtests.com\/test\/sed-rate-test\">ESR (nonspecific<\/a>)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-c-metabolic-vascular-stress-the-vascular-aging-accelerant\">C. Metabolic vascular stress (the vascular aging accelerant)<\/h3>\n\n\n\n<p><strong>Why it matters:<\/strong>&nbsp;Insulin resistance and glycemic variability damage endothelium and stiffen arteries over time.<\/p>\n\n\n\n<p>High-yield tests:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/a1c-test\">Hemoglobin A1c<\/a><\/strong><\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/glucose-test\">Fasting glucose<\/a><\/strong><\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/insulin-test\">Fasting insulin<\/a><\/strong><\/li>\n\n\n\n<li><a href=\"https:\/\/www.ultalabtests.com\/test\/comprehensive-metabolic-panel-test-cmp\">CMP markers relevant to cardiometabolic status<\/a><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-d-endothelial-and-renal-microvascular-impact\">D. Endothelial and renal microvascular impact<\/h3>\n\n\n\n<p><strong>Why it matters:<\/strong>&nbsp;The kidney is a vascular organ; microvascular injury is both a marker and amplifier of cardiovascular risk.<\/p>\n\n\n\n<p>High-yield tests:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Creatinine + eGFR<\/strong>&nbsp;(often within <a href=\"https:\/\/www.ultalabtests.com\/test\/comprehensive-metabolic-panel-test-cmp\">CMP<\/a>)<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/albumin-random-urine-test-with-creatinine\">Urine albumin\/creatinine ratio (uACR)<\/a><\/strong>&nbsp;or microalbumin<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ultalabtests.com\/test\/electrolyte-panel-test\">Electrolytes, bicarbonate as clinically indicated<\/a><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-e-thrombotic-risk-secondary-causes-selected-patients\">E. Thrombotic risk \/ secondary causes (selected patients)<\/h3>\n\n\n\n<p><strong>Why it matters:<\/strong>&nbsp;Vascular aging + inflammation increases prothrombotic milieu; also consider secondary drivers.<\/p>\n\n\n\n<p>Selected tests:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.ultalabtests.com\/test\/homocysteine-test\"><strong>Homocysteine<\/strong>&nbsp;<\/a>(contextual; interpret cautiously)<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ultalabtests.com\/test\/tsh-test\"><strong>TSH<\/strong>&nbsp;<\/a>(thyroid dysfunction impacts lipids and hemodynamics)<\/li>\n\n\n\n<li><a href=\"https:\/\/www.ultalabtests.com\/test\/complete-blood-count-with-differential-and-platelets-cbc-test\"><strong>CBC<\/strong>&nbsp;<\/a>(anemia\/polycythemia and platelet abnormalities)<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/iron-tibc-and-ferritin-panel\">Ferritin\/iron indices<\/a><\/strong>&nbsp;(inflammatory vs iron overload patterns)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-f-myocardial-stress-injury-biomarkers-when-clinically-relevant\">F. Myocardial stress\/injury biomarkers (when clinically relevant)<\/h3>\n\n\n\n<p><strong>Why it matters:<\/strong>&nbsp;Vascular aging can manifest as silent ischemia, microvascular disease, or myocardial strain.<\/p>\n\n\n\n<p>Selected tests:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/nt-probnp-test\">NT-proBNP<\/a> \/ <\/strong><a href=\"https:\/\/www.ultalabtests.com\/test\/bnp-test\"><strong>BNP<\/strong>&nbsp;<\/a>(HF risk\/strain)<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/troponin-t-high-sensitivity-test\">High-sensitivity troponin<\/a><\/strong>&nbsp;(risk phenotype in some settings; also diagnostic in acute care)<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-5-evidence-based-prevention-amp-treatment-strategies\">5) Evidence-based prevention &amp; treatment strategies<\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"427\" src=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Age-vs-Chronological-Age-Medium.jpeg?resize=640%2C427&#038;quality=100&#038;ssl=1\" alt=\"Two side-by-side silhouettes labeled \u201cOlder Arteries\u201d and \u201cYounger Arteries,\u201d both age 60, showing different vascular ages (75 vs 45) with contrasting artery\/heart visuals to illustrate vascular age vs chronological age.\" class=\"wp-image-2449\" srcset=\"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Age-vs-Chronological-Age-Medium.jpeg?w=640&amp;quality=100&amp;ssl=1 640w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Age-vs-Chronological-Age-Medium.jpeg?resize=300%2C200&amp;quality=100&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Age-vs-Chronological-Age-Medium.jpeg?resize=600%2C400&amp;quality=100&amp;ssl=1 600w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><figcaption class=\"wp-element-caption\">Two people can be the same chronological age\u2014but have very different vascular age and cardiovascular risk.<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-a-lifestyle-the-vascular-age-reset-foundation\">A. Lifestyle: the \u201cvascular age reset\u201d foundation<\/h3>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-1-nutrition-patterns-with-outcomes-data\">1) Nutrition patterns with outcomes data<\/h4>\n\n\n\n<p><strong>Mediterranean dietary pattern<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Randomized trial evidence supports reduced major cardiovascular events in high-risk individuals. (<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1800389?\" target=\"_blank\" rel=\"noreferrer noopener\">New England Journal of Medicine<\/a>)<\/li>\n<\/ul>\n\n\n\n<p><strong>DASH dietary pattern<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Demonstrated meaningful blood pressure reduction in randomized feeding trials. (<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJM199704173361601?\" target=\"_blank\" rel=\"noreferrer noopener\">New England Journal of Medicine<\/a>)<br>Because BP load is one of the strongest mechanical drivers of arterial stiffening, BP-lowering nutrition has direct implications for vascular aging.<\/li>\n<\/ul>\n\n\n\n<p><strong>Practical vascular-aging nutrition targets<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Prioritize unsaturated fats, fiber-rich carbohydrates, polyphenol-rich foods<\/li>\n\n\n\n<li>Reduce sodium (especially in salt-sensitive patients)<\/li>\n\n\n\n<li>Ensure adequate potassium\/magnesium from foods when safe (CKD requires caution)<\/li>\n\n\n\n<li>Limit ultra-processed foods that worsen insulin resistance and inflammation<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-2-exercise-and-arterial-elasticity\">2) Exercise and \u201carterial elasticity\u201d<\/h4>\n\n\n\n<p>Regular aerobic + resistance training improves endothelial function and reduces BP; it is one of the most reliable nonpharmacologic interventions to slow vascular aging physiology. (Exercise effects are also tied to mitochondrial and oxidative stress pathways discussed in vascular biology reviews.) (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8163660\/?\" target=\"_blank\" rel=\"noreferrer noopener\">PMC<\/a>)<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-3-sleep-circadian-stability-and-stress-physiology\">3) Sleep, circadian stability, and stress physiology<\/h4>\n\n\n\n<p>Poor sleep and chronic stress elevate sympathetic tone and worsen cardiometabolic markers\u2014contributing to endothelial dysfunction and stiffening over time.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-b-therapeutic-supplements-evidence-aware-clinician-cautious\">B. Therapeutic supplements (evidence-aware, clinician-cautious)<\/h3>\n\n\n\n<p>Supplements should be framed as&nbsp;<strong>adjunctive<\/strong>\u2014not replacements for BP\/LDL\/A1c control.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-1-omega-3-therapy-distinguish-otc-fish-oil-from-prescription-epa\">1) Omega-3 therapy: distinguish OTC fish oil from prescription EPA<\/h4>\n\n\n\n<p>Outcomes evidence is strongest for&nbsp;<strong>icosapent ethyl (EPA)<\/strong>&nbsp;in appropriately selected patients on statins with elevated triglycerides; it reduced cardiovascular events in a major randomized outcomes trial. (<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1812792?\" target=\"_blank\" rel=\"noreferrer noopener\">New England Journal of Medicine<\/a>)<br>Broader omega-3 results are mixed, and product\/formulation matters. (<a href=\"https:\/\/academic.oup.com\/eurjpc\/article\/31\/8\/1005\/7505348?\" target=\"_blank\" rel=\"noreferrer noopener\">OUP Academic<\/a>)<\/p>\n\n\n\n<p><strong>Clinical use:<\/strong>&nbsp;Consider for patients meeting guideline and trial-like criteria (e.g., persistent hypertriglyceridemia on statins with ASCVD or high risk).<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-2-coenzyme-q10-coq10\">2) Coenzyme Q10 (CoQ10)<\/h4>\n\n\n\n<p>Meta-analyses suggest CoQ10 supplementation can modestly reduce systolic BP in cardiometabolic populations, with dose-response signals reported. <br><strong>Clinical use:<\/strong>&nbsp;Consider in select patients (e.g., statin-associated muscle symptoms, BP optimization adjunct), recognizing outcome data are not equivalent to statins\/BP agents.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-3-cocoa-flavanols\">3) Cocoa flavanols<\/h4>\n\n\n\n<p>In COSMOS, cocoa extract supplementation did&nbsp;<strong>not<\/strong>&nbsp;significantly reduce total cardiovascular events overall, but was associated with lower CVD death and supportive secondary analyses; interpretation requires nuance. (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35294962\/?\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a>)<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-4-dietary-nitrate-beetroot-leafy-greens\">4) Dietary nitrate (beetroot\/leafy greens)<\/h4>\n\n\n\n<p>Shorter-term trials and meta-analyses support modest BP reductions, though long-term benefit signals are mixed depending on population and design.<br><strong>Clinical use:<\/strong>&nbsp;Consider as a food-first strategy (leafy greens) and as an adjunct in BP plans, with attention to kidney stone risk\/oxalate issues in susceptible individuals.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-5-vitamin-k2-for-calcification-avoid-overpromising\">5) Vitamin K2 for calcification: avoid overpromising<\/h4>\n\n\n\n<p>Randomized data have not consistently shown slowing of calcification once established (e.g., aortic valve calcification trial signals). <br><strong>Clinical use:<\/strong>&nbsp;Do not position as a proven vascular calcification therapy.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-c-peptide-and-biologic-therapies-what-s-real-today-vs-investigational\">C. Peptide and biologic therapies: what\u2019s real today vs investigational<\/h3>\n\n\n\n<p>The term \u201cpeptide therapy\u201d is used broadly in integrative\/optimization circles, but clinical evidence ranges from&nbsp;<strong>robust<\/strong>(GLP-1 receptor agonists) to&nbsp;<strong>preclinical\/investigational<\/strong>&nbsp;(mitochondrial peptides, regenerative peptides).<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-1-clinically-established-peptide-class-therapy-glp-1-receptor-agonists\">1) Clinically established peptide-class therapy: GLP-1 receptor agonists<\/h4>\n\n\n\n<p>GLP-1 RAs (peptide hormones) have strong cardiometabolic benefits and, in secondary prevention settings, have demonstrated reductions in major adverse cardiovascular events in people with overweight\/obesity and established CVD (including without diabetes in SELECT). (<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2307563?utm_source=chatgpt.com\">New Englan<\/a><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2307563?\" target=\"_blank\" rel=\"noreferrer noopener\">d Journal of Medicine<\/a>)<br><strong>Vascular aging relevance:<\/strong>&nbsp;improved weight, glycemic control, inflammation markers, and potentially endothelial function\u2014addressing multiple upstream drivers of vascular aging.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-2-mitochondrial-derived-peptides-e-g-mots-c-and-mitochondrial-targeting-peptides-e-g-elamipretide-ss-31\">2) Mitochondrial-derived peptides (e.g., MOTS-c) and mitochondrial-targeting peptides (e.g., elamipretide\/SS-31)<\/h4>\n\n\n\n<p>These are scientifically interesting, with mechanistic links to endothelial function, oxidative stress, and aging biology. However, much of the vascular-aging relevance remains translational rather than guideline-based. (<a href=\"https:\/\/www.jci.org\/articles\/view\/158449?\" target=\"_blank\" rel=\"noreferrer noopener\">JCI<\/a>)<br><strong>Clinical positioning:<\/strong>&nbsp;investigational\/early-stage; not standard of care for vascular aging prevention.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-3-regenerative-peptides-popular-online-example-bpc-157\">3) Regenerative peptides popular online (example: BPC-157)<\/h4>\n\n\n\n<p>The medical literature notes&nbsp;<strong>limited human data<\/strong>&nbsp;and emphasizes investigational status and safety uncertainty. <br><strong>Clinical positioning:<\/strong>&nbsp;not evidence-based for vascular aging\/CVD prevention; risks include product quality and lack of rigorous trials.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-d-pharmacologic-strategies-where-outcome-data-are-strongest\">D. Pharmacologic strategies (where outcome data are strongest)<\/h3>\n\n\n\n<p>For vascular aging, the pharmacologic \u201cbig levers\u201d target:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>LDL\/apoB particle burden<\/strong><\/li>\n\n\n\n<li><strong>Blood pressure and hemodynamic load<\/strong><\/li>\n\n\n\n<li><strong>Inflammation in select secondary prevention patients<\/strong><\/li>\n\n\n\n<li><strong>Metabolic disease (diabetes\/obesity)<\/strong><\/li>\n\n\n\n<li><strong>Thrombosis prevention in appropriate ASCVD contexts<\/strong><\/li>\n<\/ol>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-1-lipid-lowering-ascvd-prevention-cornerstone\">1) Lipid-lowering (ASCVD prevention cornerstone)<\/h4>\n\n\n\n<p>Guideline frameworks for chronic coronary disease and ASCVD risk reduction emphasize statins as first-line, with add-on therapies when LDL-C remains above thresholds on maximally tolerated statin therapy. (<a href=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000001168?\" target=\"_blank\" rel=\"noreferrer noopener\">AHA Journals<\/a>)<br>Common escalation pathway includes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Statin \u2192 ezetimibe \u2192 PCSK9 inhibitor<\/strong><br>with other options (e.g., bempedoic acid, inclisiran) depending on risk, tolerance, and access. <\/li>\n<\/ul>\n\n\n\n<p><strong>Vascular aging rationale:<\/strong>&nbsp;Lowering apoB-containing particles slows plaque progression and stabilizes existing plaque\u2014reducing event risk even if \u201cvascular age\u201d is advanced.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-2-blood-pressure-control-stiffness-driver\">2) Blood pressure control (stiffness driver)<\/h4>\n\n\n\n<p>Because arterial stiffening and BP amplify each other, BP optimization is \u201canti\u2013vascular aging.\u201d European hypertension guidance highlights PWV as a marker of target organ damage and risk, reinforcing the importance of hemodynamic control. <br>Clinically: RAAS blockade (ACEi\/ARB), thiazide-like diuretics, calcium channel blockers\u2014chosen based on phenotype and comorbidities.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-3-anti-inflammatory-therapy-in-secondary-prevention-selected-patients\">3) Anti-inflammatory therapy in secondary prevention (selected patients)<\/h4>\n\n\n\n<p>Low-dose colchicine has demonstrated reductions in cardiovascular events in chronic coronary disease\/stable atherosclerosis populations in major trials. <br><strong>Vascular aging rationale:<\/strong>&nbsp;downshifts inflammatory signaling implicated in plaque activity.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-4-metabolic-pharmacotherapy-diabetes-obesity-driven-vascular-aging\">4) Metabolic pharmacotherapy (diabetes\/obesity-driven vascular aging)<\/h4>\n\n\n\n<p>GLP-1 RAs (and, in appropriate patients, SGLT2 inhibitors\u2014outside the scope of citations gathered here) can reduce events and improve cardiometabolic drivers.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-6-putting-it-into-practice-a-clinician-ready-vascular-aging-workup\">6) Putting it into practice: a clinician-ready vascular aging workup<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-a-when-to-suspect-accelerated-vascular-aging\">A. When to suspect \u201caccelerated vascular aging\u201d<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hypertension with widening pulse pressure<\/li>\n\n\n\n<li>Diabetes\/insulin resistance, metabolic syndrome<\/li>\n\n\n\n<li>CKD or albuminuria<\/li>\n\n\n\n<li>Family history of premature ASCVD or high Lp(a)<\/li>\n\n\n\n<li>Discordant lipids (normal LDL-C but high ApoB \/ TG-rich phenotype)<\/li>\n\n\n\n<li>Inflammatory disorders, sleep apnea, smoking history<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-b-baseline-evaluation-high-yield\">B. Baseline evaluation (high-yield)<\/h3>\n\n\n\n<p><strong>Vitals\/physiology<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Home BP + office BP; consider ambulatory BP monitoring<\/li>\n\n\n\n<li>Pulse pressure, orthostatic measures (as indicated)<\/li>\n<\/ul>\n\n\n\n<p><strong>Vascular structure\/function<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>CAC scoring or carotid plaque assessment in borderline\/intermediate-risk decisions<\/li>\n\n\n\n<li>PWV or central pressure testing when available\/impactful<\/li>\n<\/ul>\n\n\n\n<p><strong>Laboratory panel<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Lipid panel + ApoB<\/li>\n\n\n\n<li>Lp(a) (at least once)<\/li>\n\n\n\n<li>hs-CRP<\/li>\n\n\n\n<li>A1c \u00b1 fasting glucose\/insulin (as appropriate)<\/li>\n\n\n\n<li>CMP (renal function, electrolytes, liver markers)<\/li>\n\n\n\n<li>uACR (microvascular risk)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-c-follow-up-track-what-changes\">C. Follow-up (track what changes)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ApoB \/ non\u2013HDL-C response to therapy<\/li>\n\n\n\n<li>hs-CRP trend in high-risk patients (contextual)<\/li>\n\n\n\n<li>A1c and metabolic markers<\/li>\n\n\n\n<li>uACR and eGFR trajectory<\/li>\n\n\n\n<li>Repeat imaging only when it changes management<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-7-suggested-ulta-lab-tests\">7) Suggested Ulta Lab Tests <\/h2>\n\n\n\n<p>If you\u2019re choosing&nbsp;<strong>one<\/strong>&nbsp;panel to start with, the&nbsp;<strong>Vascular Aging &amp; Arterial Health Baseline Panel<\/strong>&nbsp;is the smartest \u201cfirst step\u201d because it gives you a clear, actionable snapshot of your cardiovascular risk from multiple angles\u2014<strong>atherogenic burden (ApoB + Lipoprotein(a)), inflammation (hs-CRP), metabolic control (A1c + CMP), and early kidney stress (urine albumin\/creatinine)<\/strong>. Instead of relying on cholesterol alone, this baseline helps you spot hidden risk earlier, prioritize what to address first, and create a set of numbers you can reliably&nbsp;<strong>track over time<\/strong>&nbsp;to see whether lifestyle changes or treatment are actually improving arterial health.<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/vascular-aging-arterial-health-baseline-panel\">Vascular Aging &amp; Arterial Health Baseline Panel<\/a><\/strong> - A comprehensive cardiovascular baseline that measures&nbsp;<strong>ApoB, Lipoprotein(a), hs-CRP, A1c, a full lipid panel, CMP metabolic markers, and urinary albumin\/creatinine<\/strong>&nbsp;to assess&nbsp;<strong>vascular aging, arterial risk, inflammation, metabolic health, and early kidney stress<\/strong>\u2014ideal for proactive prevention and long-term trending.<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Lipid Panel<\/li>\n\n\n\n<li>ApoB<\/li>\n\n\n\n<li>Lp(a)<\/li>\n\n\n\n<li>hs-CRP<\/li>\n\n\n\n<li>A1c<\/li>\n\n\n\n<li>CMP<\/li>\n\n\n\n<li>uACR (urine albumin\/creatinine)<\/li>\n<\/ul>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/atherosclerosis-coronary-heart-disease-risk-refinement-panel\" type=\"link\" id=\"https:\/\/www.ultalabtests.com\/test\/atherosclerosis-coronary-heart-disease-risk-refinement-panel\" target=\"_blank\" rel=\"noreferrer noopener\">Atherosclerosis &amp; Coronary Heart Disease Risk Refinement Panel<\/a><\/strong> - An advanced risk stratification panel that goes beyond standard cholesterol by evaluating&nbsp;<strong>particle number\/size (Ion Mobility), ApoB, Lipoprotein(a), hs-CRP, homocysteine, TSH, and a full lipid panel<\/strong>&nbsp;to refine&nbsp;<strong>atherosclerosis\/CHD risk<\/strong>, inflammation, and key metabolic\/hormonal contributors.<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Lipid Panel + advanced lipoproteins<\/li>\n\n\n\n<li>ApoB<\/li>\n\n\n\n<li>Lp(a)<\/li>\n\n\n\n<li>hs-CRP<\/li>\n\n\n\n<li>Homocysteine (optional, clinician preference)<\/li>\n\n\n\n<li>TSH (if clinically indicated)<\/li>\n<\/ul>\n\n\n\n<ol start=\"3\" class=\"wp-block-list\">\n<li><strong><a href=\"https:\/\/www.ultalabtests.com\/test\/vascular-aging-impact-end-organ-surveillance-panel\" target=\"_blank\" rel=\"noreferrer noopener\">Vascular Aging Impact &amp; End-Organ Surveillance Panel<\/a><\/strong> - A surveillance-focused panel designed to monitor downstream effects of vascular aging by assessing&nbsp;<strong>cardiac strain (NT-proBNP), myocardial injury (hs Troponin T), glycemic control (A1c), kidney function (urinary albumin\/creatinine + CMP), and systemic health (CBC)<\/strong>&nbsp;for structured, proactive end-organ monitoring.<\/li>\n<\/ol>\n\n\n\n<ul class=\"wp-block-list\">\n<li>CMP (kidney + electrolytes)<\/li>\n\n\n\n<li>uACR<\/li>\n\n\n\n<li>CBC<\/li>\n\n\n\n<li>NT-proBNP (selected patients)<\/li>\n\n\n\n<li>hs-troponin (selected patients \/ clinician-directed)<\/li>\n\n\n\n<li>A1c<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-clinical-takeaway\">Clinical takeaway<\/h2>\n\n\n\n<p>Vascular aging is a&nbsp;<strong>measurable disease process<\/strong>, not an inevitability. The most effective clinical strategy is to identify vascular aging early using a combination of:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Functional signals (PWV\/endothelial function)<\/li>\n\n\n\n<li>Structural burden (CAC\/plaque)<\/li>\n\n\n\n<li>Lab phenotyping (ApoB, Lp(a), hs-CRP, metabolic and renal markers)<\/li>\n<\/ul>\n\n\n\n<p>Then, treat aggressively where the evidence is strongest:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Lower apoB particle burden<\/strong><\/li>\n\n\n\n<li><strong>Control BP and hemodynamic load<\/strong><\/li>\n\n\n\n<li><strong>Address insulin resistance and obesity<\/strong><\/li>\n\n\n\n<li><strong>Target inflammation in select secondary prevention patients<\/strong><\/li>\n\n\n\n<li>Use supplements and emerging peptide strategies&nbsp;<strong>only<\/strong>&nbsp;as adjuncts, and only when evidence and safety warrant.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Vascular aging is not simply \u201ctime passing.\u201d It is a measurable, biologically driven remodeling of the arterial system\u2014centered on endothelial dysfunction,&nbsp;Arterial Stiffness&nbsp;(often described as&nbsp;artery stiffness), vascular inflammation, and calcific\/atherosclerotic progression\u2014that ultimately amplifies risk for ASCVD, [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":2444,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[149,198,81,6,153,145,151,146,194,196,85],"tags":[1664,1776,1982,1983,445,1899,1985,1766,1965,1890,302,478,557,1986,1763,1900,1984,1987,1981],"class_list":["post-2443","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cholesterol","category-chronic-inflammation","category-diabetes","category-heart-and-cardiovascular","category-all-heart-and-cardiovascular","category-heart-disease","category-heart-health","category-high-blood-pressure-hypertension","category-inflammation","category-all-inflammation","category-insulin-resistance","tag-advanced-lipid-testing","tag-apob","tag-arterial-stiffness","tag-ascvd","tag-atherosclerosis","tag-cardiovascular-risk","tag-coronary-artery-disease","tag-endothelial-dysfunction","tag-hemoglobin-a1c","tag-hs-crp","tag-hypertension","tag-inflammation","tag-insulin-resistance","tag-ldl-particles","tag-lipoproteina","tag-lpa","tag-pulse-wave-velocity","tag-urine-albumin-creatinine-ratio","tag-vascular-aging"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Vascular Aging &amp; Cardiovascular Risk: Labs, Prevention, Therapy | Ulta Lab Tests<\/title>\n<meta name=\"description\" content=\"Vascular aging fuels ASCVD and hypertension\u2014learn the key early biomarkers and evidence-based nutrition, supplements, peptides, and meds.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vascular Aging &amp; Cardiovascular Risk: Labs, Prevention, Therapy\" \/>\n<meta property=\"og:description\" content=\"Vascular aging fuels ASCVD and hypertension\u2014learn the key early biomarkers and evidence-based nutrition, supplements, peptides, and meds.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Ulta Lab Tests\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/ultalabtests\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-26T18:12:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-28T16:07:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Medium.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"John R\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"John R\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"13 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Vascular Aging &amp; Cardiovascular Risk: Labs, Prevention, Therapy | Ulta Lab Tests","description":"Vascular aging fuels ASCVD and hypertension\u2014learn the key early biomarkers and evidence-based nutrition, supplements, peptides, and meds.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/","og_locale":"en_US","og_type":"article","og_title":"Vascular Aging &amp; Cardiovascular Risk: Labs, Prevention, Therapy","og_description":"Vascular aging fuels ASCVD and hypertension\u2014learn the key early biomarkers and evidence-based nutrition, supplements, peptides, and meds.","og_url":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/","og_site_name":"Ulta Lab Tests","article_publisher":"https:\/\/facebook.com\/ultalabtests","article_published_time":"2026-02-26T18:12:39+00:00","article_modified_time":"2026-02-28T16:07:07+00:00","og_image":[{"width":640,"height":640,"url":"https:\/\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Medium.jpeg","type":"image\/jpeg"}],"author":"John R","twitter_card":"summary_large_image","twitter_misc":{"Written by":"John R","Est. reading time":"13 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/#article","isPartOf":{"@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/"},"author":{"name":"John R","@id":"https:\/\/www.ultalabtests.com\/blog\/#\/schema\/person\/e9af1f4fe34b68909911dc95c313ed6a"},"headline":"Vascular Aging &amp; Cardiovascular Risk: Labs, Prevention, Therapy","datePublished":"2026-02-26T18:12:39+00:00","dateModified":"2026-02-28T16:07:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/"},"wordCount":2795,"commentCount":0,"publisher":{"@id":"https:\/\/www.ultalabtests.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?fit=640%2C640&quality=100&ssl=1","keywords":["Advanced Lipid Testing","ApoB","arterial stiffness","ASCVD","Atherosclerosis","Cardiovascular Risk","coronary artery disease","endothelial dysfunction","Hemoglobin A1c","hs-CRP","hypertension","inflammation","Insulin Resistance","LDL particles","lipoprotein(a)","Lp(a)","pulse wave velocity","urine albumin creatinine ratio","vascular aging"],"articleSection":["Cholesterol","Chronic Inflammation","Diabetes","Heart &amp; Cardiovascular","Heart and Cardiovascular","Heart Disease","Heart Health","High Blood Pressure (Hypertension)","Inflammation","Inflammation","Insulin Resistance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/","url":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/","name":"Vascular Aging &amp; Cardiovascular Risk: Labs, Prevention, Therapy | Ulta Lab Tests","isPartOf":{"@id":"https:\/\/www.ultalabtests.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/#primaryimage"},"image":{"@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?fit=640%2C640&quality=100&ssl=1","datePublished":"2026-02-26T18:12:39+00:00","dateModified":"2026-02-28T16:07:07+00:00","description":"Vascular aging fuels ASCVD and hypertension\u2014learn the key early biomarkers and evidence-based nutrition, supplements, peptides, and meds.","breadcrumb":{"@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/#primaryimage","url":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?fit=640%2C640&quality=100&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?fit=640%2C640&quality=100&ssl=1","width":640,"height":640,"caption":"Key vascular-aging biomarkers and therapy levers\u2014ApoB, Lp(a), inflammation, and metabolic risk\u2014brought together in one visual."},{"@type":"BreadcrumbList","@id":"https:\/\/www.ultalabtests.com\/blog\/heart-and-cardiovascular\/vascular-aging-cardiovascular-risk-labs-prevention-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ulta Lab Tests","item":"https:\/\/www.ultalabtests.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Heart &amp; Cardiovascular","item":"https:\/\/www.ultalabtests.com\/blog\/category\/heart-and-cardiovascular\/"},{"@type":"ListItem","position":3,"name":"Vascular Aging &amp; Cardiovascular Risk: Labs, Prevention, Therapy"}]},{"@type":"WebSite","@id":"https:\/\/www.ultalabtests.com\/blog\/#website","url":"https:\/\/www.ultalabtests.com\/blog\/","name":"Ulta Lab Tests","description":"You Order the Test. We&#039;ll Do the Rest!","publisher":{"@id":"https:\/\/www.ultalabtests.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ultalabtests.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ultalabtests.com\/blog\/#organization","name":"Ulta Lab Tests","url":"https:\/\/www.ultalabtests.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ultalabtests.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2023\/02\/logo.png?fit=405%2C79&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2023\/02\/logo.png?fit=405%2C79&ssl=1","width":405,"height":79,"caption":"Ulta Lab Tests"},"image":{"@id":"https:\/\/www.ultalabtests.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/ultalabtests","http:\/\/www.linkedin.com\/company\/3335617"]},{"@type":"Person","@id":"https:\/\/www.ultalabtests.com\/blog\/#\/schema\/person\/e9af1f4fe34b68909911dc95c313ed6a","name":"John R","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d48f9c8356694121fd9e2793e13d6aa6855e5df11f9b14f7a872b4ea554581fb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d48f9c8356694121fd9e2793e13d6aa6855e5df11f9b14f7a872b4ea554581fb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d48f9c8356694121fd9e2793e13d6aa6855e5df11f9b14f7a872b4ea554581fb?s=96&d=mm&r=g","caption":"John R"}}]}},"featured_image_src":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?resize=600%2C400&quality=100&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?resize=600%2C600&quality=100&ssl=1","author_info":{"display_name":"John R","author_link":"https:\/\/www.ultalabtests.com\/blog\/author\/johnroehmultalabtests-com\/"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.ultalabtests.com\/blog\/wp-content\/uploads\/2026\/02\/Vascular-Aging-Cardiovascular-Risk-Medium.jpeg?fit=640%2C640&quality=100&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/posts\/2443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/comments?post=2443"}],"version-history":[{"count":0,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/posts\/2443\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/media\/2444"}],"wp:attachment":[{"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/media?parent=2443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/categories?post=2443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ultalabtests.com\/blog\/wp-json\/wp\/v2\/tags?post=2443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}